Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

"The most common symptoms I hear from my patients are leg cramping or discomfort with walking. They often tell me they can ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with incident bipolar disorder (BD), according to a study published online Feb. 11 ...

People with kidney disease may be at higher risk of anxiety and depression. But taking care of your mental health can have a positive effect on your outlook with kidney disease. Chronic kidney ...

Lithium is associated with an increased risk for thyroid dysfunction and chronic kidney disease (CKD) in patients with ...

According to a 2019 review, up to 84% of people with end stage chronic kidney disease develop pruritus. The authors state that recent advancements in dialysis treatments have helped bring the ...

Several risk tools can accurately predict individual baseline risks of adverse events in people with chronic kidney disease. Here, the authors examine methods of assessing risk and discuss risk ...

The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...

Efficacy was established based on the time to first occurrence of a primary composite endpoint event, defined as onset of persistent 50% or greater reduction in eGFR according to the Chronic Kidney ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

HONOLULU (KHON2) — Peripheral Artery Disease is a common condition ... And it most commonly affects people with diabetes, chronic kidney disease or smoking. It’s quite common here in Hawaii ...